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Characteristics and treatment of inducible flutter associated with typical atrioventricular reentrant nodal tachycardia in pediatric patients
Nicolas Lellouche (1), Kevin Shannon (2), Noel Boyle (2), Jean-Luc Dubois-Randé (1), Kalyanam Shikkumar (2) (1) CHU Henri Mondor, Fédération de Cardiologie, Créteil, UCLA Cardiac Arrhythmia Center, Los Angeles, Etats-Unis Background: Atrioventricular reentrant nodal tachycardia (AVNRT) and right atrial flutter could have a common area in the perinodal myocardium. We studied the occurrence of inducible flutter in pediatric patients with AVNRT or atrioventricular reentrant tachycardia (AVRT). Moreover we studied the effect of slowpathway ablation on flutter inducibility.
Methods and Results:
We included 110 children (mean age=12±4 years), without underlying heart disease, previous ablation or history of atrial flutter or fibrillation, who were referred for supraventricular tachycardia ablation. Thirty-seven (34%) patients had AVNRT and 73 (66%) had AVRT. A standardized protocol of flutter induction was used in all these patients at baseline and after ablation. All patients with AVNRT had immediate successfull slowpathway ablation. Ninety-nine percent of patients with AVRT had immediate successfull accessory pathway ablation. Pediatric patients with AVNRT had inducible flutter in 14% of cases whereas no patient with AVRT had inducible flutter (p=0.001). After slowpathway ablation, including a line between the low tricuspid valve and the coronary sinus ostium, no inducible flutter was found in the AVNRT and AVRT group. In the AVNRT group, patients with inducible flutter had shorter baseline AH interval (67±14 vs. 88±21 ms, p=0.04), AV Wenckebach (294±67 vs. 404±101 ms, p=0.02) and VA Wenckebach (298±48 vs. 403±98 ms, p=0.04) compared to other AVNRT patients.
Conclusion:
These results suggest that AVNRT and right atrial flutter could share a common area located in the perinodal myocardium. However the slowpathway may not correspond to the slow conduction area during atrial flutter. Large slowpathway ablation could abolish flutter inducibilty.
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Similar implantable defibrillator event rates in patients with unexplained syncope and left ventricular dysfunction whatever the result of electrophysiological testing.
Annabelle Dinan, Bertrand Pierre, Noura Zannad, Nicolas Clémenty, Olivier Marie, Laurent Fauchier, Dominique Babuty
CHU Tours, Cardiologie B, Chambray -Les-Tours, France
Objectives: The purpose of this study was to evaluate the ventricular arrhythmias (VA) frequency in patients with unexplained syncope, ischemic or non-ischemic cardiac disease and left ventricular dysfunction (LVEF) and negative electrophysiological study (EP), implanted with cardioverter-defibrillator (ICD).
Background: According to the current guidelines, EP is performed to evaluate syncope in patients with significant altered LVEF, mainly to guide treatment by ICD. Limited data concerning incidence of ventricular events in patients with no inducible arrhythmias is available.
Methods:
We evaluated 58 consecutive patients with unexplained syncope who underwent EP. All patients had a depressed LVEF (< 45 %). Sustained VA was only inducible in 28 patients (VF n=8, SMVT n=20). All patients were treated with ICD. We compared primary endpoint of severe VA in patients with negative and positive EP.
Results:
Baseline characteristic were similar in the both groups. In the population (97% men), mean age was 67±10 years, 67% had ischemic cardiopathy; mean LVEF was 30±7 % in non inducible group, 32±9 % in inducible group (p = 0.16). During the follow-up (25±22 months), 22 severe VA occurred; Kaplan-Meier analysis of time to first appropriate ICD therapy for non-inducible and inducible VA showed overlapping curves (p =0.9), with 11 (37%) and 11 (39%) events in each group. Sub-group analysis according to LVEF and etiology of cardiopathy did not show significant difference.
Conclusions:
In patients with unexplained syncope, ischemic or non-ischemic cardiopathy and left ventricular dysfunction, severe VA occurs in the follow-up at same rate whatever the result of EP. This study suggests that these patients should be treated with ICD without doing electrophysiological testing. Most of studies show the interest to decrease ventricular pacing in patients implanted with a dual chamber pacemaker (PM). Algorithms developed to search spontaneous ventricular activity consisted first in increasing AV delay
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